Literature DB >> 8743279

Transforming growth factor-alpha regulates subpopulation of giant cells which secrete mouse placental lactogen-I (mPL-I) and/or mPL-II at midpregnancy.

M Yamaguchi1, K Ogura, M Sakata, A Miyake.   

Abstract

The aim of this study was to determine whether transforming growth factor-alpha (TGF-alpha) regulates expression of mouse placental lactogen-I (mPL-I) and mPL-II at midpregnancy in vitro. Treatment of placental cells from day 9 of pregnancy with TGF-alpha resulted in stimulation of mPL-I secretion and inhibition of mPL-II secretion in a time- and dose-dependent manner without changing the amount of newly synthesized trichloroacetic acid precipitable proteins and cell viability. Moreover, TGF-alpha increased the intra-cellular mPL-I concentration and immuno-precipitable newly synthesized mPL-I concentration both in the medium and cells. TGF-alpha increased the number of cells containing only mPL-I and cells containing both mPL-I and mPL-II, but decreased that of the cells containing only mPL-II assessed by double immunocytochemistry. TGF-alpha increased the number of cells releasing only mPL-I but decreased the number of cells releasing only mPL-II, however TGF-alpha did not affect the number of cells releasing both mPL-I and mPL-II assessed by sequential reverse hemolytic plaque assay (RHPA). TGF-alpha decreased the expression of mPL-II mRNA, but did not change the expression of mPL-I mRNA. In situ hybridization for epidermal growth factor receptor (EGF-R) after RHPA for mPL-I indicated that giant cells releasing mPL-I express EGF-R mRNA. These findings suggest that TGF-alpha regulates the subpopulation of giant cells which produces and releases mPL-I and mPL-II and it results in an increase of mPL-I secretion and decrease of mPL-II secretion, and suggests possible post-transcriptional stimulation of mPL-I secretion and transcriptional inhibition of mPL-II secretion by TGF-alpha. Giant cells releasing mPL-I express EGF-R mRNA, suggesting direct regulation of giant cell differentiation by EGF and TGF-alpha at midpregnancy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743279     DOI: 10.1007/bf03349857

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  23 in total

1.  Measurement of peptide secretion and gene expression in the same cell.

Authors:  K Scarbrough; N G Weiland; G H Larson; M A Sortino; S F Chiu; A N Hirshfield; P M Wise
Journal:  Mol Endocrinol       Date:  1991-01

2.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.

Authors:  A B Schreiber; M E Winkler; R Derynck
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

3.  Selective inhibition of mouse placental lactogen II secretion by tumour necrosis factor-alpha.

Authors:  M Yamaguchi; L Ogren; R Barnard; T Imai; T Sawada; A Miyake; F Talamantes
Journal:  J Endocrinol       Date:  1994-10       Impact factor: 4.286

4.  Cyclic adenosine 3',5'-monophosphate stimulation of placental proliferin and proliferin-related protein secretion.

Authors:  M Yamaguchi; T Imai; T Maeda; M Sakata; A Miyake; D I Linzer
Journal:  Endocrinology       Date:  1995-05       Impact factor: 4.736

5.  Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha.

Authors:  B S Gan; M D Hollenberg; K L MacCannell; K Lederis; M E Winkler; R Derynck
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

6.  Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro.

Authors:  K J Ibbotson; J Harrod; M Gowen; S D'Souza; D D Smith; M E Winkler; R Derynck; G R Mundy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Developmental expression of transforming growth factors alpha and beta in mouse fetus.

Authors:  J N Wilcox; R Derynck
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

8.  Tumor necrosis factor-alpha (TNF-alpha) inhibits expression of mouse placental lactogen-II through TNF-alpha type-I but not type-II receptor.

Authors:  M Yamaguchi; H Kurachi; C Tadokoro; M Sakata; Y Yoshimoto; N Masumoto; K Tasaka; A Miyake
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

9.  Co-localization of placental lactogen-I, placental lactogen-II, and proliferin in the mouse placenta at midpregnancy.

Authors:  M Yamaguchi; L Ogren; H Endo; M J Soares; F Talamantes
Journal:  Biol Reprod       Date:  1994-12       Impact factor: 4.285

10.  Mouse placental lactogen-I: RIA and gestational profile in maternal serum.

Authors:  L Ogren; J N Southard; P Colosi; D I Linzer; F Talamantes
Journal:  Endocrinology       Date:  1989-11       Impact factor: 4.736

View more
  1 in total

1.  Regulation of mouse placental lactogen-II secretion by transforming growth factor-alpha after midpregnancy.

Authors:  M Yamaguchi; K Kobayashi; A Miyake
Journal:  J Endocrinol Invest       Date:  1996-10       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.